# Brookside Capital: portfolio, investments and team

> Brookside Capital is a hedge fund based in United States. 40 investments on record, latest Sept 2015. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/brookside-capital (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Brookside Capital

Filed with the SEC to raise a fund in Feb 2024, closing $8,914M. Last cheque observed Sep 2015.

Quiet New fund $8.9B, Feb 2024 Hedge fund Website unconfirmed

Series C Series D Series B Identity Management Social Media Biotechnology

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 40 on record

Since the last cheque **4051** days **00** hrs **00** min **00** sec

Median round **$50M** Rounds led **0 of 40** Exits **10 from the portfolio** Mostly in **United States, 85%**

Pitch Brookside Capital

## Brookside Capital highlights

- 01 40 rounds on record
- 02 Mostly Series C and Series D: 53% of its rounds
- 03 10 exits from the portfolio

## What they do

- **Type:** Hedge fund (from a list, unverified)
- **Cheque size:** Not stated
- **Sectors:** Identity Management Social Media Biotechnology
- **Based in:** United States
- **Cold pitches:** Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. [Tell us the right one](https://millionrounds.com/corrections?slug=brookside-capital).

## The record

Every round we can evidence, newest first **40 appearances**

- **2015** 8 rounds
- **Sept** **[SevOne, Inc.](https://millionrounds.com/company/sevone-inc)** Series C · US **$50M** With 4 others
- **Jul** **[Giosis](https://millionrounds.com/company/giosis)** Series A · SG **$82M** With 5 others
- **Jul** **[Qoo10-Indonesia](https://millionrounds.com/company/qoo10-indonesia)** Series A · ID **$82M** With 5 others
- **May** **[REGENXBIO](https://millionrounds.com/company/regenxbio)** Series D · US **$71M** With 12 others
- **May** **[MuleSoft](https://millionrounds.com/company/mulesoft)** Series G · US **$128M** With 13 others
- **May** **[DocuSign](https://millionrounds.com/company/docusign)** Series F · US **$233M** With 10 others
- **Apr** **[Voyager Therapeutics](https://millionrounds.com/company/voyager-therapeutics)** Series B · US **$60M** With 3 others
- **Jan** **[REGENXBIO](https://millionrounds.com/company/regenxbio)** Series C · US **$30M** With 3 others
- **2014** 3 rounds
- **May** **[Spark Therapeutics](https://millionrounds.com/company/spark-therapeutics)** Series B · US **$73M** With 5 others
- **May** **[Anaplan](https://millionrounds.com/company/anaplan)** Series D · US **$100M** With 7 others
- **Feb** **[NJOY](https://millionrounds.com/company/njoy)** Growth · US **$70M** With 1 other
- **2013** 4 rounds
- **Dec** **[Zafgen](https://millionrounds.com/company/zafgen)** Series E · US · finsmes.com **$45M** With 3 others
- **Jul** **[Dicerna Pharmaceuticals](https://millionrounds.com/company/dicerna-pharmaceuticals)** Series C · US · finsmes.com **$60M** With 8 others
- **Apr** **[Radius Health](https://millionrounds.com/company/radius-health)** Growth · US · finance.yahoo.com **$43M** With 5 others
- **Mar** **[PTC Therapeutics](https://millionrounds.com/company/ptc-therapeutics)** Growth · US · finsmes.com **$60M** With 8 others
- **2012** 1 round
- **Feb** **[Radius Health](https://millionrounds.com/company/radius-health)** Series C · US · onbiovc.com **$21M** With 6 others
- **2011** 2 rounds
- **Dec** **[Radius Health](https://millionrounds.com/company/radius-health)** Growth · US **$21M** With 6 others
- **Jul** **[Radius Health](https://millionrounds.com/company/radius-health)** Series C · US · onbiovc.com **$66M** With 6 others
- **2010** 1 round
- **Apr** **[Brightcove](https://millionrounds.com/company/brightcove)** Series D · US · paidcontent.org **$12M** With 6 others
- **2009** 3 rounds
- **Dec** **[Youku](https://millionrounds.com/company/youku)** Series E · CN · businessinsider.com **$40M** With 3 others
- **Jun** **[Portola Pharmaceuticals](https://millionrounds.com/company/portola-pharmaceuticals)** Series C · US **$60M** With 17 others
- **Mar** **[Thumbplay](https://millionrounds.com/company/thumbplay)** Series F · US **$8.0M** With 5 others
- **2008** 4 rounds
- **Jun** **[Youku](https://millionrounds.com/company/youku)** Series D · CN · paidcontent.org **$40M** With 4 others
- **May** **[Sohu.com](https://millionrounds.com/company/sohu-com)** Venture · CN **$25M** With 3 others
- **Apr** **[Concert Pharmaceuticals](https://millionrounds.com/company/concert-pharmaceuticals)** Series C · US **$37M** With 11 others
- **Mar** **[Thumbplay](https://millionrounds.com/company/thumbplay)** Series E · US · venturebeat.com **$18M** With 1 other
- **2007** 8 rounds
- **Dec** **[REVA Medical](https://millionrounds.com/company/reva-medical)** Venture · US **$42M** With 5 others
- **Nov** **[Virtual Iron Software](https://millionrounds.com/company/virtual-iron-software)** Series D · US · virtualization.info **$13M** With 6 others
- **Nov** **[Youku](https://millionrounds.com/company/youku)** Series C · CN · jlmpacificepoch.com **$25M** With 3 others
- **May** **[Portola Pharmaceuticals](https://millionrounds.com/company/portola-pharmaceuticals)** Series C · US **$70M** With 11 others
- **Mar** **[MAP Pharmaceuticals](https://millionrounds.com/company/map-pharmaceuticals)** Series D · US · deals.venturebeat.com **$50M** With 5 others
- **Feb** **[Targanta Therapeutics](https://millionrounds.com/company/targanta-therapeutics)** Series C · US **$70M** With 3 others
- **Jan** **[diaDexus](https://millionrounds.com/company/diadexus)** Series E · US · scalevp.com **$40M** With 6 others
- **Jan** **[Brightcove](https://millionrounds.com/company/brightcove)** Series C · US · paidcontent.org **$60M** With 10 others
- **2006** 2 rounds
- **Nov** **[Concert Pharmaceuticals](https://millionrounds.com/company/concert-pharmaceuticals)** Series B · US · concertpharma.com **$49M** With 7 others
- **Jun** **[Tengion](https://millionrounds.com/company/tengion)** Series B · US · tengion.com **$50M** With 6 others
- **2005** 3 rounds
- **May** **[MetaSolv](https://millionrounds.com/company/metasolv)** Venture · US **$22M** With 5 others
- **Feb** **[Perlegen Sciences](https://millionrounds.com/company/perlegen-sciences)** Series D · US · allbusiness.com **$74M** With 14 others
- **Feb** **[FibroGen](https://millionrounds.com/company/fibrogen)** Series F · US · fibrogen.com **$100M** With 14 others
- **2004** 1 round
- **Mar** **[Eyetel Imaging](https://millionrounds.com/company/eyetel-imaging)** Series B · US **$11M** With 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **24 named**

AM **Adam Max Koppel** Executive Officer i Filing they signed

AM **Anad More** Executive Officer i Filing they signed

AC **Anand Christopher More** PARTNER OF THE INVESTMENT ADVISER i Filing they signed

AW **Andrew W. Viens** MANAGING DIRECTOR OF THE INVESTMENT ADVISOR i Filing they signed

CL **Corey L. Sclar** Managing Member of General Partner i Filing they signed

DD **David D. Buttolph** Managing Member of General Partner i Filing they signed

DM **Davis Michael Clayson** Executive Officer i Filing they signed

DG **Dennis G. Goldstein** Executive Officer i Filing they signed

DC **Devon C. Burger** Member of the General Partner i Filing they signed

DJ **Dewey John Awad** MANAGING DIRECTOR OF THE INVESTMENT ADVISOR i Filing they signed

DJ **Domenic Jay Ferrante** Executive Officer i Filing they signed

DJ **Douglas J. Rudisch** Executive Officer i Filing they signed

EM **Ed Michael Brakeman** Executive Officer i Filing they signed

EF **Emily F. Mccomb** Executive Officer i Filing they signed

FM **Ferat Michael Ongoren** MANAGING DIRECTOR OF THE INVESTMENT ADVISOR i Filing they signed

FM **Fernando Michael Vigil** Executive Officer i Filing they signed

GC **Gregory C. Foy** Member of the General Partner i Filing they signed

GW **Gregory William Moore** Executive Officer i Filing they signed

JM **John Michael Toussaint** PARTNER OF THE INVESTMENT ADVISER i Filing they signed

JL **John L. Irwin III** Managing Member of General Partner i Filing they signed

JN **John N. Irwin** Member of the General Partner i Filing they signed

JM **Joshua Michael Ross** MANAGING DIRECTOR AND CHIEF INVESTMENT OFFICER OF THE INVESTMENT ADVISOR i Filing they signed

MC **Mark Christopher Moore** Executive Officer i Filing they signed

MM **Mark Mcpherron** Executive Officer i Filing they signed

We also hold **74** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Exits from the portfolio

Companies it backed that were later bought or listed **10 in all**

**[PTC Therapeutics](https://millionrounds.com/company/ptc-therapeutics)** Listed **$125M** Jun 2013

**[Portola Pharmaceuticals](https://millionrounds.com/company/portola-pharmaceuticals)** Listed **$100M** May 2013

**[MAP Pharmaceuticals](https://millionrounds.com/company/map-pharmaceuticals)** Bought by [Allergan](https://millionrounds.com/fund/allergan) **$958M** Jan 2013

**[Brightcove](https://millionrounds.com/company/brightcove)** Listed **Undisclosed** Feb 2012

**[Thumbplay](https://millionrounds.com/company/thumbplay)** Bought by [iHeartMedia](https://millionrounds.com/fund/iheartmedia) **Undisclosed** Mar 2011

**[Youku](https://millionrounds.com/company/youku)** Listed **Undisclosed** Dec 2010

**[Tengion](https://millionrounds.com/company/tengion)** Listed **Undisclosed** Apr 2010

**[Virtual Iron Software](https://millionrounds.com/company/virtual-iron-software)** Bought by [Oracle Corporation](https://millionrounds.com/fund/oracle) **Undisclosed** May 2009

**[Eyetel Imaging](https://millionrounds.com/company/eyetel-imaging)** Bought by NeuroMetrix **$10M** Dec 2007

**[MetaSolv](https://millionrounds.com/company/metasolv)** Bought by [Oracle Corporation](https://millionrounds.com/fund/oracle) **Undisclosed** Oct 2006

An exit counts when it came after the firm's first round in the company. From historical deal records.

New fund on file

**$8.9B**

raised in Feb 2024

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Series C Series D Series B

Median round joined **$50M** the round, not its cheque

Led 0 of 40 rounds **0%**

- **Sole investor:** Never alone
- **Last cheque:** Sept 2015
- **Exits:** 10 from the portfolio

Rounds by stage said on their site

- Series C *11*
- Series D *7*
- Series B *5*
- Growth *4*
- Series E *4*
- Venture *3*

Cheques by year Led Joined

2004 2015

Often in the room with

- [MPM Capital](https://millionrounds.com/fund/mpm-bioimpact) 7
- [Sutter Hill Ventures](https://millionrounds.com/fund/sutter-hill-ventures) 6
- [Adage Capital Management](https://millionrounds.com/fund/adage-capital-management) 5
- [Maverick Capital](https://millionrounds.com/fund/maverick-capital) 5
- [Skyline Ventures](https://millionrounds.com/fund/skyline-ventures) 5
- [AllianceBernstein](https://millionrounds.com/fund/alliancebernstein) 4

**Pitching Brookside Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Brookside Capital. A count of rooms they were both in, not a relationship either has claimed.

[**MPM Capital** Private equity **7** rounds together](https://millionrounds.com/fund/mpm-bioimpact)[**Sutter Hill Ventures** VC firm **6** rounds together](https://millionrounds.com/fund/sutter-hill-ventures)[**Adage Capital Management** Asset manager **5** rounds together](https://millionrounds.com/fund/adage-capital-management)[**Maverick Capital** VC firm **5** rounds together](https://millionrounds.com/fund/maverick-capital)[**Skyline Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/skyline-ventures)[**AllianceBernstein** VC firm **4** rounds together](https://millionrounds.com/fund/alliancebernstein)[**BB Biotech Ventures** Growth equity **4** rounds together](https://millionrounds.com/fund/bb-biotech-ventures)[**Bain Capital Ventures** VC firm **4** rounds together](https://millionrounds.com/fund/bain-capital-ventures)[**Chengwei Capital** VC firm **4** rounds together](https://millionrounds.com/fund/chengwei-capital)[**Goldman Sachs** Private equity **4** rounds together](https://millionrounds.com/fund/goldman-sachs)[**T. Rowe Price** Private equity **4** rounds together](https://millionrounds.com/fund/t-rowe-price)[**Abingworth** VC firm **3** rounds together](https://millionrounds.com/fund/abingworth)

## Quick answers about Brookside Capital

### What does Brookside Capital invest in?

Brookside Capital invests most often at Series C and Series D (53% of the rounds on record), in sectors such as Identity Management, Social Media and Biotechnology.

### How active is Brookside Capital?

40 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2015.

### How big are Brookside Capital's cheques?

The median round it joins is $50M.

### Does Brookside Capital lead rounds?

Rarely, if at all: none of its 40 investments on record names it as the lead.

### Where does Brookside Capital invest?

Most of the companies it backs are in the United States (85%) and China (10%).

### Is Brookside Capital investing now?

No investments in the last 12 months; the latest was in Sept 2015.

### Who does Brookside Capital invest alongside?

Most often MPM Capital (7 rounds together), Sutter Hill Ventures (6 rounds together) and Adage Capital Management (5 rounds together).

### What kind of investor is Brookside Capital?

Brookside Capital is a hedge fund based in United States.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=brookside-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=brookside-capital)